Loading company…
Swiss AI imaging software company whose TBS Osteo tool helps assess bone health and predict osteoporosis fracture risk.
Medimaps Group SA develops AI imaging software that assesses bone health and fracture risk, with its TBS Osteo product applied to DXA bone densitometry scans. Founded in 2006 in Switzerland, it sells to hospitals in the United States, Canada and Europe, and TBS Osteo is used in 16 of the 20 hospitals on the U.S. News Best Hospitals Honor Roll. In November 2021 it raised USD 20.00 mn in Series C funding led by Swisscanto Invest by Zürcher Kantonalbank, with Swiss Entrepreneurs Foundation, Swisscom Ventures and Verve Ventures participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in